Hwang, S.; Kim, J.H.; Kim, U.; Ha, H.I.; Park, S.-Y.; Lim, M.C.
Influence of Residual Disease on the Efficacy of PARP Inhibitors in Advanced Epithelial Ovarian Cancer: A Systematic Review and Meta Analysis. Cancers 2025, 17, 3365.
https://doi.org/10.3390/cancers17203365
AMA Style
Hwang S, Kim JH, Kim U, Ha HI, Park S-Y, Lim MC.
Influence of Residual Disease on the Efficacy of PARP Inhibitors in Advanced Epithelial Ovarian Cancer: A Systematic Review and Meta Analysis. Cancers. 2025; 17(20):3365.
https://doi.org/10.3390/cancers17203365
Chicago/Turabian Style
Hwang, Sekyoung, Ji Hyun Kim, Uisuk Kim, Hyeong In Ha, Sang-Yoon Park, and Myong Cheol Lim.
2025. "Influence of Residual Disease on the Efficacy of PARP Inhibitors in Advanced Epithelial Ovarian Cancer: A Systematic Review and Meta Analysis" Cancers 17, no. 20: 3365.
https://doi.org/10.3390/cancers17203365
APA Style
Hwang, S., Kim, J. H., Kim, U., Ha, H. I., Park, S.-Y., & Lim, M. C.
(2025). Influence of Residual Disease on the Efficacy of PARP Inhibitors in Advanced Epithelial Ovarian Cancer: A Systematic Review and Meta Analysis. Cancers, 17(20), 3365.
https://doi.org/10.3390/cancers17203365